Men with prostate cancer who were treated with the GnRH agonist leuprolide had significantly more coronary artery plaque progression than those receiving the GnRH antagonist relugolix.

A DRUG that shrinks tumours in patients with untreatable prostate cancer has shown “remarkable” results, scientists have said. The treatment, called VIR-5500, harnesses the body’s immune system to ...

Two types of androgen deprivation therapy (ADT) had different effects on coronary atherosclerosis in a small randomized trial of men with prostate cancer. Significantly more coronary artery plaque ...

Side effects of Ozempic seem to be similar in males and females. Some evidence suggests that females may be more likely to have side effects from GLP-1 receptor agonists, but this hasn’t been ...

Share on Pinterest People who lose weight with GLP-1 drugs are likely to continue using the medication despite the side effects. Image Credit: geckophotos/Getty Images A recent study found that many ...

A massive review of 23 randomized trials found that statins do not cause the vast majority of side effects listed on their labels. Memory problems, depression, sleep issues, weight gain, and many ...

A minimally invasive targeted treatment called salvage focal therapy, which targets just the cancerous area of the prostate, can treat men whose prostate cancer has recurred after radiotherapy with ...

Taking shilajit supplements may have benefits for male fertility and bone health. You can find shilajit as dissolvable powders and capsules. Research on its safety is limited, so it's best to check ...

Eighty-five original research projects from aspiring physician-scientists were on display at the 2026 Medical Student Research Forum at the Jacobs School of Medicine and Biomedical Sciences.